SEC filing · 8-K

LB Pharmaceuticals Inc: Executive or director change

LB Pharmaceuticals appointed Susan G. Kozauer, M.D. as Chief Medical Officer effective September 14, 2026.

Filed September 15, 2026

Positive for the company

What happened

LB Pharmaceuticals appointed Dr. Susan G. Kozauer as Chief Medical Officer starting September 14, 2026.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov Press release (EX-99.1) All documents of this filing

Back to LB Pharmaceuticals Inc

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.